Medicago Inc.

Canada


Commandez votre montre hebdomadaire Medicago Inc.
Quantité totale PI 135
Rang # Quantité totale PI 9 877
Note d'activité PI 2,5/5.0    38
Rang # Activité PI 19 719
Parent Mitsubishi Tanabe Pharma Corporation
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

9 20
5 25
45 5
26
 
Dernier brevet 2024 - Modified influenza b virus hemag...
Premier brevet 2000 - Method for regulating transcript...
Dernière marque 2021 - MEDICAGO HEALTH IS IN OUR NATURE
Première marque 2004 - MEDICAGO

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Modified coronavirus s protein. The present disclosure relates to modified coronavirus S protein ...
2022 Invention Modified influenza b virus hemagglutinin. The present disclosure relates to the production of mod...
Invention Recombinant influenza virus-like particles (vlps) produced in transgenic plants. A method for sy...
2021 P/S Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic pro...
Invention Cpmv vlps displaying sars-cov-2 epitopes. The present disclosure relates to the production of mod...
Invention Modified coronavirus structural protein. Modified coronaviras spike (S)-protein, virus-like parti...
P/S Human vaccines for preventing and treating coronaviruses diseases and disorders
P/S Human vaccines.
P/S Human vaccines.
Invention Suprastructure comprising modified influenza hemagglutinin with reduced interaction with sialic a...
P/S Vaccines for human use.
2020 Invention Nicotiana benthamiana plant or cell with reduced xylt and fuct. Nicotiana varieties) that are sui...
P/S Human vaccines for treatment and prevention of coronaviruses
Invention Virus like particle production in plants. A method of producing a virus like particle (VLP) in a...
P/S Human vaccines
P/S Human vaccines
P/S Human vaccines for the prevention and treatment of SARS-COV2, COVID-19, and coronavirus diseases ...
Invention Rotavirus vp7 fusion proteins and rotavirus-like particles comprising them. Nucleic acids encodi...
Invention Rotavirus vp7 fusion proteins and rotavirus-like particles comprising them. Nucleic acids encodin...
P/S Pharmaceutical and medicinal preparations and substances namely human vaccines, therapeutic prote...
2019 P/S Pharmaceutical and medicinal preparations and substances namely human vaccines, therapeutic prot...
P/S Human influenza vaccine
P/S Human influenza vaccine
P/S Human influenza vaccines
Invention Influenza virus hemagglutinin mutants. The present invention relates to the production of modifie...
P/S Wholesale store services featuring pharmaceuticals, pharmaceutical ingredients, vaccines, therape...
Invention Endogenous plant expression enhancer. An isolated expression enhancer active in a plant, portion ...
Invention Plant expression enhancer. An isolated expression enhancer active in a plant, portion of a plant ...
2018 Invention Picornavirus-like particle production in plants. A method of producing a picornavirus-like partic...
Invention Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins. Nucleic acid...
P/S Pharmaceutical and medicinal preparations and substances namely therapeutic proteins and antibodi...
P/S Human influenza vaccine.
P/S Human influenza vaccine.
Invention Norovirus fusion proteins and vlps comprising norovirus fusion proteins. Nucleic acids encoding n...
2017 Invention Modifying n-glycosylation of plant proteins using gdp-4-dehydro-6-deoxy-d-mannose reductase (rmd)...
P/S Vaccines for human use; viral vaccines.
2016 Invention Jasmonic acid pathway activator. A method of increasing expression of an heterologous protein of ...
Invention Rotavirus-like particle production in plants. A method of producing a rotavirus-like particle (RL...
2015 Invention Modifying protein production in plants. A method for synthesizing a protein of interest within a ...
Invention Modified cpmv enhancer elements. An expression enhancer comprising, in series, a CPMV 5′UTR nucle...
Invention Modified cpmv enhancer elements. An expression enhancer comprising, in series, a CPMV 5'UTR nucle...
Invention Cpmv enhancer elements. An expression enhancer comprising a CPMV 5'UTR nucleotide sequence consis...
2014 Invention Influenza virus-like particle production in plants. A method of producing a virus like particle (...
2013 Invention Method for making nicotiana plants with mutations in xylt and fuct alleles using rare-cutting end...
Invention Plants for production of therapeutic proteins. Materials and methods are provided for making plan...
Invention Plants for production of therapeutic proteins. Materials and Methods are provided for making pla...
Invention Plant infiltration tray. A plant tray for receiving and retaining one or more plant pots includes...
Invention Rotavirus-like particle production in plants. A method of producing a virus-like particle (VLP) ...
Invention Rotavirus-like particle production in plants. A method of producing a virus-like particle (VLP) i...
Invention Plant infiltration device. It is provided a plant infiltration device for infiltrating plants wit...
2012 Invention Increasing virus-like particle yield in plants. A method of producing a virus like particle (VLP)...
Invention Rabies virus like particle production in plants. A method of producing a virus like particle (VL...
Invention Rabies virus like particle production in plants. A method of producing a virus like particle (VLP...
Invention Affinity trapping agent and uses thereof. A nucleic acid encoding an affinity trapping agent is p...
Invention Method of recovering plant-derived proteins. Methods of recovering plant-derived proteins or supr...
2011 Invention Virus like particle production in plants. A method of producing a virus like particle (VLP) in a ...
Invention Plant expression system. A plant expression system and methods for expressing a protein of inter...
Invention Plant expression system. A plant expression system and methods for expressing a protein of intere...
2009 Invention Influenza virus immunizing epitope. A method for synthesizing influenza virus-like particles (VLP...
Invention Soluble recombinant influenza antigens. The present invention provides a recombinant soluble trim...